vs
GoDaddy（GDDY）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
GoDaddy的季度营收约是Revvity的1.7倍（$1.3B vs $772.1M），GoDaddy净利率更高（19.2% vs 12.7%，领先6.5%），GoDaddy同比增速更快（6.8% vs 5.9%），GoDaddy自由现金流更多（$363.7M vs $161.8M），过去两年Revvity的营收复合增速更高（9.0% vs 7.2%）
GoDaddy是美国上市的互联网域名注册管理、域名服务及网络托管服务商，总部位于亚利桑那州坦佩。2023年按市场份额计为全球第五大网络主机服务商，管理超6200万个注册域名，旗下2000万用户中绝大多数为中小微企业，是全球领先的互联网基础服务供应商。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
GDDY vs RVTY — 直观对比
营收规模更大
GDDY
是对方的1.7倍
$772.1M
营收增速更快
GDDY
高出1.0%
5.9%
净利率更高
GDDY
高出6.5%
12.7%
自由现金流更多
GDDY
多$201.9M
$161.8M
两年增速更快
RVTY
近两年复合增速
7.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $772.1M |
| 净利润 | $245.1M | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | 24.9% | 14.5% |
| 净利率 | 19.2% | 12.7% |
| 营收同比 | 6.8% | 5.9% |
| 净利润同比 | 23.4% | 3.9% |
| 每股收益（稀释后） | — | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GDDYRVTY
| Q4 25 | $1.3B | $772.1M | ||
| Q3 25 | $1.3B | $698.9M | ||
| Q2 25 | $1.2B | $720.3M | ||
| Q1 25 | $1.2B | $664.8M | ||
| Q4 24 | $1.2B | $729.4M | ||
| Q3 24 | $1.1B | $684.0M | ||
| Q2 24 | $1.1B | $691.7M | ||
| Q1 24 | $1.1B | $649.9M |
净利润GDDYRVTY
| Q4 25 | $245.1M | $98.4M | ||
| Q3 25 | $210.5M | $46.7M | ||
| Q2 25 | $199.9M | $53.9M | ||
| Q1 25 | $219.5M | $42.2M | ||
| Q4 24 | $198.6M | $94.6M | ||
| Q3 24 | $190.5M | $94.4M | ||
| Q2 24 | $146.3M | $55.4M | ||
| Q1 24 | $401.5M | $26.0M |
毛利率GDDYRVTY
| Q4 25 | — | — | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 54.6% |
营业利润率GDDYRVTY
| Q4 25 | 24.9% | 14.5% | ||
| Q3 25 | 23.4% | 11.7% | ||
| Q2 25 | 21.9% | 12.6% | ||
| Q1 25 | 20.7% | 10.9% | ||
| Q4 24 | 21.4% | 16.3% | ||
| Q3 24 | 22.1% | 14.3% | ||
| Q2 24 | 18.5% | 12.4% | ||
| Q1 24 | 15.9% | 6.8% |
净利率GDDYRVTY
| Q4 25 | 19.2% | 12.7% | ||
| Q3 25 | 16.6% | 6.7% | ||
| Q2 25 | 16.4% | 7.5% | ||
| Q1 25 | 18.4% | 6.4% | ||
| Q4 24 | 16.7% | 13.0% | ||
| Q3 24 | 16.6% | 13.8% | ||
| Q2 24 | 13.0% | 8.0% | ||
| Q1 24 | 36.2% | 4.0% |
每股收益（稀释后）GDDYRVTY
| Q4 25 | — | $0.86 | ||
| Q3 25 | $1.51 | $0.40 | ||
| Q2 25 | $1.41 | $0.46 | ||
| Q1 25 | — | $0.35 | ||
| Q4 24 | — | $0.77 | ||
| Q3 24 | $1.32 | $0.77 | ||
| Q2 24 | $1.01 | $0.45 | ||
| Q1 24 | — | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $215.1M | $7.3B |
| 总资产 | $8.0B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GDDYRVTY
| Q4 25 | — | $919.9M | ||
| Q3 25 | — | $931.4M | ||
| Q2 25 | — | $991.8M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | — | $1.7B |
股东权益GDDYRVTY
| Q4 25 | $215.1M | $7.3B | ||
| Q3 25 | $91.8M | $7.4B | ||
| Q2 25 | $404.4M | $7.6B | ||
| Q1 25 | $199.7M | $7.6B | ||
| Q4 24 | $692.1M | $7.7B | ||
| Q3 24 | $356.7M | $7.9B | ||
| Q2 24 | $157.0M | $7.9B | ||
| Q1 24 | $414.8M | $7.8B |
总资产GDDYRVTY
| Q4 25 | $8.0B | $12.2B | ||
| Q3 25 | $8.0B | $12.1B | ||
| Q2 25 | $8.3B | $12.4B | ||
| Q1 25 | $7.8B | $12.4B | ||
| Q4 24 | $8.2B | $12.4B | ||
| Q3 24 | $8.0B | $12.8B | ||
| Q2 24 | $7.7B | $13.4B | ||
| Q1 24 | $8.0B | $13.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $370.6M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $363.7M | $161.8M |
| 自由现金流率自由现金流/营收 | 28.6% | 21.0% |
| 资本支出强度资本支出/营收 | 0.5% | 2.6% |
| 现金转化率经营现金流/净利润 | 1.51× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $1.6B | $509.4M |
8季度趋势，按日历期对齐
经营现金流GDDYRVTY
| Q4 25 | $370.6M | $182.0M | ||
| Q3 25 | $444.2M | $138.5M | ||
| Q2 25 | $379.9M | $134.3M | ||
| Q1 25 | $404.7M | $128.2M | ||
| Q4 24 | $340.5M | $174.2M | ||
| Q3 24 | $355.2M | $147.9M | ||
| Q2 24 | $294.8M | $158.6M | ||
| Q1 24 | $297.2M | $147.6M |
自由现金流GDDYRVTY
| Q4 25 | $363.7M | $161.8M | ||
| Q3 25 | $434.9M | $120.0M | ||
| Q2 25 | $375.8M | $115.5M | ||
| Q1 25 | $401.1M | $112.2M | ||
| Q4 24 | $326.1M | $149.8M | ||
| Q3 24 | $350.2M | $125.6M | ||
| Q2 24 | $292.0M | $136.6M | ||
| Q1 24 | $292.8M | $129.7M |
自由现金流率GDDYRVTY
| Q4 25 | 28.6% | 21.0% | ||
| Q3 25 | 34.4% | 17.2% | ||
| Q2 25 | 30.9% | 16.0% | ||
| Q1 25 | 33.6% | 16.9% | ||
| Q4 24 | 27.3% | 20.5% | ||
| Q3 24 | 30.5% | 18.4% | ||
| Q2 24 | 26.0% | 19.7% | ||
| Q1 24 | 26.4% | 20.0% |
资本支出强度GDDYRVTY
| Q4 25 | 0.5% | 2.6% | ||
| Q3 25 | 0.7% | 2.6% | ||
| Q2 25 | 0.3% | 2.6% | ||
| Q1 25 | 0.3% | 2.4% | ||
| Q4 24 | 1.2% | 3.4% | ||
| Q3 24 | 0.4% | 3.3% | ||
| Q2 24 | 0.2% | 3.2% | ||
| Q1 24 | 0.4% | 2.7% |
现金转化率GDDYRVTY
| Q4 25 | 1.51× | 1.85× | ||
| Q3 25 | 2.11× | 2.97× | ||
| Q2 25 | 1.90× | 2.49× | ||
| Q1 25 | 1.84× | 3.03× | ||
| Q4 24 | 1.71× | 1.84× | ||
| Q3 24 | 1.86× | 1.57× | ||
| Q2 24 | 2.02× | 2.87× | ||
| Q1 24 | 0.74× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GDDY
| Domains | $586.5M | 46% |
| Applications And Commerce | $497.7M | 39% |
| Other | $189.7M | 15% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
